Therapy of cardioneurosis with modern antidepressants in general medical care network
- 15 October 2021
- journal article
- research article
- Published by Alfmed LLC in Medical alphabet
- No. 25,p. 26-32
Abstract
The clinical presentation of cardioneurosis is heterogeneous and includes anxiety-phobic, cenestalgic, and depressive symptoms. General practitioners, who most often see this category of patients, usually recommend to take «sedatives». Modern antidepressant, i. e. selective serotonin reuptake inhibitor, escitalopram demonstrated high efficiency and good tolerability in patients with cardoneurosis (neurocirculatory dystonia).Keywords
This publication has 21 references indexed in Scilit:
- Escitalopram in the treatment of anxiety symptoms associated with depressionDepression and Anxiety, 2006
- Efficacy of escitalopram in patients with severe depression: a pooled analysisInternational Journal Of Clinical Practice, 2005
- Escitalopram in the treatment of social anxiety disorder: Analysis of efficacy for different clinical subgroups and symptom dimensionsDepression and Anxiety, 2004
- Escitalopram in the Treatment of Panic DisorderThe Journal of Clinical Psychiatry, 2003
- Enantiomers' potential in psychopharmacology—a critical analysis with special emphasis on the antidepressant escitalopramEuropean Neuropsychopharmacology, 2002
- Stereoisomers in PsychiatryThe Primary Care Companion For CNS Disorders, 2002
- The antidepressant effects of citalopram are mediated by the S-(+)- and not the R(−)-enantiomerEuropean Neuropsychopharmacology, 1999
- Neurocirculatory asthenia: a reassessment using modern psychosomatic criteriaActa Psychiatrica Scandinavica, 1994
- Amplification, Somatization, and the Somatoform DisordersPsychosomatics, 1992
- Cardiac Neurosis and PsychopathologyPsychotherapy and Psychosomatics, 1989